What happened
ST Pharm disclosed a supply contract, worth US$59.8M, about 32.8% of its recent annual revenue, running through Nov 2027.
For context, this single contract equals about 32.8% of the company's most recent annual revenue.
| Counterparty | Disclosed |
|---|---|
| Contract value | US$59.8M |
| vs. recent revenue | 32.8% |
| Through | Nov 2027 (from Mar 2026) |
| Filed | 2026-03-16, Supply contract signed |
| Source | DART rcept 20260316901006 → open original filing |
Source: DART. Information only, not investment advice.